ECONOMIC EVALUATION OF DENGUE DISEASE IMPACT: AN ANALYSIS FOR SÃO PAULO CONTEXT

Authors

DOI:

https://doi.org/10.24325/issn.2446-5763.v11i32p228-242

Keywords:

Hospitalizations, Costs and Cost Analysis, Public health

Abstract

Dengue is an arboviral disease with a high incidence in tropical regions, exerting a substantial burden on public health and healthcare systems. In recent years, the municipality of São Paulo has experienced a progressive rise in the number of dengue cases and related hospitalizations. This study aims to examine the temporal evolution of dengue incidence, hospital admissions, and associated healthcare costs in São Paulo from 2007 to 2025. An observational, ecological, time-series design was employed, utilizing publicly available secondary data. Epidemiological indicators, hospitalization records, and cost-related data were obtained from the Hospital Information System of the Brazilian Unified Health System (SIH/SUS). Trends in case counts, incidence rates, hospital admissions, total expenditures, and hospital service costs were systematically analyzed. The results are presented through descriptive tables and graphical representations. The findings reveal a marked increase in both the absolute number of dengue cases and incidence rates over the study period, with an epidemic peak observed in 2024. A concomitant rise in the frequency and complexity of hospitalizations was identified, resulting in a substantial escalation of hospital-related expenditures. The emergence and co-circulation of multiple dengue virus serotypes, coupled with elevated levels of immunological susceptibility within the population, contributed to the severity of recent outbreaks. Dengue continues to pose a critical public health challenge in São Paulo, with growing implications for healthcare infrastructure and the financial sustainability of the Unified Health System. The implementation of integrated vector control measures, enhanced epidemiological surveillance, and expanded vaccination coverage is imperative to curb the spread of the disease, reduce the burden of hospitalizations, and mitigate associated economic costs.

Downloads

Download data is not yet available.

Author Biographies

Ana Flávia Barbosa Gabriel

Doutoranda

Instituto de Ciências Ambientais, Químicas e Farmacêuticas

UNIFESP - Universidade Federal de São Paulo

Programa de Pós-Graduação em Biologia Química

Daniela Debone

Doutora

Instituto de Ciências Ambientais, Químicas e Farmacêuticas

UNIFESP - Universidade Federal de São Paulo

Programa de Pós-Graduação em Análise Ambiental Integrada

ARIES, Antimicrobial Resistance Institute of São Paulo, São Paulo, Brazil.

Ronan Adler Tavella

Doutor

Instituto de Ciências Ambientais, Químicas e Farmacêuticas

UNIFESP - Universidade Federal de São Paulo

Programa de Pós-Graduação em Análise Ambiental Integrada

ARIES, Antimicrobial Resistance Institute of São Paulo, São Paulo, Brazil.

Simone Georges El Khouri Miraglia

Professor Doutor

Instituto de Ciências Ambientais, Químicas e Farmacêuticas

UNIFESP - Universidade Federal de São Paulo

Programa de Pós-Graduação em Biologia Química

Programa de Pós-Graduação em Análise Ambiental Integrada

ARIES, Antimicrobial Resistance Institute of São Paulo, São Paulo, Brazil.

References

Colón-González FJ, Perera R, Lake IR, et al. Projecting the risk of mosquito-borne diseases in a warmer and more populated world: a multi-model, multi-scenario intercomparison modelling study. Lancet Planet Health. 2021;5(7):e404–e414. doi: 10.1016/S2542-5196(21)00132-7.

Schaffner F, Mathis A. Dengue and dengue vectors in the WHO European region: past, present, and scenarios for the future. Lancet Infect Dis. 2014;14(12):1271–80. doi: 10.1016/S1473-3099(14)70934-9.

Salehi M, Tabatabaei SA, Soltani S, et al. Global dengue fever management in health systems: identifying strategies, challenges and solutions–a scoping review protocol. BMJ Open. 2025;15(4):e097085. doi: 10.1136/bmjopen-2024-097085

BRASIL. Ministério da Saúde. Secretaria de ciência e tecnologia e insumos estratégicos. Departamento de ciência e tecnologia. Diretrizes metodológicas: diretriz de avaliação econômica. 2. ed. Brasília: Ministério da Saúde, 2014.

BRASIL. Ministério da Saúde. Monitoramento das arboviroses e balanço de encerramento do Comitê de Operações de Emergência (COE) Dengue e outras Arboviroses. Secretaria de Vigilância em Saúde e Ambiente, v. 55, n. 11, p. 1-32, 2024a.

BRASIL. Ministério da Saúde. Atualização de casos de arboviroses. Painel de Monitoramento das arboviroses, 2024b. Disponível em: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/a/aedes-aegypti/monitoramento-das-arboviroses.

MEDEIROS, Eduardo Alexandrino. Desafios no controle da epidemia da dengue no Brasil. Acta Paulista de Enfermagem, v. 37, p. eEDT012, 2024.

SILVA, Everton Nunes da; SILVA, Marcus Tolentino; PEREIRA, Maurício Gomes. Estudos de avaliação econômica em saúde: definição e aplicabilidade aos sistemas e serviços de saúde. Epidemiologia e Serviços de Saúde, v. 25, n. 1, p. 205-207, 2016a.

SILVA, Everton Nunes da; SILVA, Marcus Tolentino; PEREIRA, Maurício Gomes. Identificação, mensuração e valoração de custos em saúde. Epidemiologia e Serviços de Saúde, v. 25, n. 2, p. 437-439, 2016b.

Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. New York: Oxford University Press; 2005.

OLIVEIRA, Michele Lessa de; SANTOS, Leonor Maria Pacheco; SILVA, Everton Nunes da. Bases metodológicas para estudos de custos da doença no Brasil. Revista de Nutrição, v. 27, n. 5, p. 585-595, 2014.

AKBAR, Naeema A. et al. The economic burden of dengue fever in the Kingdom of Saudi Arabia. PLoS Neglected Tropical Diseases, v. 14, n. 11, p. e0008847, 2020.

SOUZA, Caio Santos de; ROMANO, Camila Malta. Dengue in the cooling off period of the COVID-19 epidemic in Brazil: from the shadows to the spotlight. Revista Do Instituto de Medicina Tropical de São Paulo, v. 64, p. e44, 2022.

MENDES, Antônio da Cruz Gouveia et al. Avaliação do Sistema de Informações Hospitalares-SIH/SUS como fonte complementar na vigilância e monitoramento de doenças de notificação compulsória. Informe Epidemiológico do SUS, v. 9, n. 2, p. 67-86, 2000.

LESSA, Fábio José Delgado et al. Novas metodologias para vigilância epidemiológica: uso do Sistema de Informações Hospitalares-SIH/SUS. Informe Epidemiológico do SUS, v. 9, p. 3-19, 2000.

Marengo JA et al. A seca e a crise hídrica de 20142015 em São Paulo. Rev USP. 2015; 106:3144.

Marcondes CB et al. Zika virus in Brazil and the danger of infestation by Aedes (Stegomyia) mosquitoes. Rev Soc Bras Med Trop. 2016; 49(1):410.

FUJITA, Dennis Minoru et al. Dengue and climate changes: Increase of DENV-1 in São Paulo/Brazil–2023. Travel medicine and infectious disease, v. 56, p. 102668, 2023.

Messina JP, Brady OJ, Scott TW, Zou C, Pigott DM, Duda KA, et al. Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol. 2014;22(3):138–46. doi: 10.1016/j.tim.2013.12.011

Schaffner F, Mathis A. Dengue and dengue vectors in the WHO European region: past, present, and scenarios for the future. Lancet Infect Dis. 2014;14(12):1271–80. doi: 10.1016/S1473-3099(14)70934-9

ANDRIOLI, Denise Catarina; BUSATO, Maria Assunta; LUTINSKI, Junir Antonio. Spatial and temporal distribution of dengue in Brazil, 1990-2017. PLoS One, v. 15, n. 2, p. e0228346, 2020.

VANNI, Tazio et al. Avaliação econômica em saúde: aplicações em doenças infecciosas. Cadernos de Saúde Pública, v. 25, p. 2543-2552, 2009.

JO, Changik. Cost-of-illness studies: concepts, scopes, and methods. Clinical and Molecular Hepatology, v. 20, n. 4, p. 327, 2014.

TAN, S. S. Microcosting in Economic Evaluations: Issues of accuracy, feasibility, consistency and generalizability. Erasmus University Rotterdam, 2009.

BEATTY, M. E.; BEUTELS, P.; MELTZER, M. I.; et al. Health economics of dengue: a systematic literature review and expert panel’s assessment. American Journal of Tropical Medicine & Hygiene, v. 84, n. 3, p. 473–488, 2011.

Roiz D, Wilson AL, Scott TW, et al. The rising global economic costs of invasive Aedes mosquitoes and Aedes-borne diseases. Sci Total Environ. 2024;933:173054. doi: 10.1016/j.scitotenv.2024.173054

SHEPARD, Donald S. et al. Economic impact of dengue illness in the Americas. The American Journal of Tropical Medicine and Hygiene, v. 84, n. 2, p. 200-207, 2011.

TEICH, Vanessa; ARINELLI, Roberta; FAHHAM, Lucas. Aedes aegypti e sociedade: o impacto econômico das arboviroses no Brasil. JBES: Brazilian Journal of Health Economics/Jornal Brasileiro de Economia da Saúde, v. 9, n. 3, 2017.

MARTELLI, Celina Maria Turchi et al. Economic impact of dengue: multicenter study across four Brazilian regions. PLoS Neglected Tropical Diseases, v. 9, n. 9, p. e0004042, 2015.

Instituto Brasileiro de Geografia e Estatística (IBGE). Cidades e Estados. Disponível em: < https://www.ibge.gov.br/cidades-e-estados/sp/sao-paulo.html>.

Prefeitura de São Paulo. Dados epidemiológicos dengue. Disponível em: < https://prefeitura.sp.gov.br/web/saude/w/vigilancia_em_saude/boletim_covisa/245603>.

Sistema de Informações Hospitalares do SUS (SIH-SUS). Disponível em: < http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sih/cnv/niro.def>.

Published

2025-08-24

How to Cite

Barbosa Gabriel, A. F., Debone, D., Adler Tavella, R., & Georges El Khouri Miraglia, S. (2025). ECONOMIC EVALUATION OF DENGUE DISEASE IMPACT: AN ANALYSIS FOR SÃO PAULO CONTEXT. South American Development Society Journal, 11(32), 228. https://doi.org/10.24325/issn.2446-5763.v11i32p228-242

Similar Articles

> >> 

You may also start an advanced similarity search for this article.